1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

Details for Australian Patent Application No. 2010322287 (hide)

Owner The Regents of the University of Michigan

Inventors Glick, Gary D.

Agent Spruson & Ferguson

Pub. Number AU-A-2010322287

PCT Pub. Number WO2011/062766

Priority 61/262,017 17.11.09 US

Filing date 3 November 2010

Wipo publication date 26 May 2011

International Classifications

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/437 (2006.01)

A61K 31/5513 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/062766 Priority application(s): WO2011/062766

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010322288-Valved catheter with integrated pressure measurement capabilities

2010322286-1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties